ESPE Abstracts (2023) 97 P1-572

1Developmental Endocrinology Research Group, University of Glasgow, Glasgow, United Kingdom. 2Office for Rare Conditions, Royal Hospital for Children, Glasgow, United Kingdom. 3Department of Paediatric Endocrinology, University Hospital Southampton, Southampton, United Kingdom. 4Division of Urology, Seattle Children's Hospital, Seattle, USA. 5Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine. 6"Dr. César Bergadá" (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina. 7Department of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil. 8Department of Paediatric and Adolescent Endocrinology, University Children's Hospital, Krakow, Poland. 9Department of Endocrinology and Diabetes, The Royal Children’s Hospital Melbourne, Parkville, Australia. 10https://home.i-dsd.org/i-dsd-gonadectomy-surveillance-consortium/, Glasgow, United Kingdom


Introduction: Gonadectomy may be indicated in people with differences or disorders of sex development (DSD). Based on historical data from the International-DSD (I-DSD) Registry that showed considerable practice variation, this I-DSD care quality improvement project seeks to determine, through prospective surveillance, the frequency of gonadectomy in individuals with DSD internationally.

Methods: All existing I-DSD centres were invited to participate; the study commenced in December 2022. Participating centres are sent a monthly email asking if a gonadectomy has been performed in a suspected or confirmed case of DSD. Where informed consent for inclusion in the I-DSD Registry has been obtained in a reported case, a secondary survey is issued to capture additional information on clinical management and outcomes. The study remains open to new I-DSD centres.

Results: Of 208 centres invited, 76 (37%) centres from 33 countries spanning all continents have been reporting monthly. Of the centres, the median (range) number of cases in the registry was 132 (1, 328). During the first 4 months of surveillance, a total of 34 gonadectomies have been reported from 22 (29%) centres in 15 (45%) countries. Of centres reporting a case, a median of 1 (0, 5) gonadectomy has been reported per centre. So far, 13/34 (38%) reported cases have been registered on the Registry with secondary surveys complete from 6 of these. Reported underlying diagnoses were disorder of gonadal development (n=3, [50%]), disorder of androgen action (n=2, [33%]) and chromosomal DSD n=1 [17%]). Five (83%) children were assigned female; median (range) age was 5.5yrs (3, 16). Gonadal position was intra-abdominal in five (83%) children and labio-scrotal in one (17%) child. Indications for gonadectomy included: mitigation of tumour risk in gonads with documented absence of function / gonadal insufficiency (n=3 [50%], all bilateral), abnormal gonad at laparoscopy (n=1[17%], unilateral), current hormone production incongruent with gender identity (n=1[17%], bilateral) and at parental request (n=1[17%], bilateral). Two children had atypical neoplastic change evident at histopathology: gonadoblastoma (n=1[17%]) and both dysgerminoma and seminoma (n=1[17%]). All individuals had been seen by a multidisciplinary team at a specialist centre for at least 1 year prior to gonadectomy.

Conclusions: Approximately 9 gonadectomies are currently reported in total per month in DSD specialist centres that are associated with I-DSD. The I-DSD platform shows clear utility for performing prospective surveillance of rare procedures; such studies are essential for care quality improvement and to inform future studies.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.